BSE briefing
This article was originally published in The Tan Sheet
Executive Summary
FDA consumer meeting on bovine spongiform encephalopathy and transmissible spongiform encephalopathies (TSE) to be held at Holiday Inn Capitol in Washington, D.C. April 16 from 1:00 p.m. to 4:30 p.m., agency announces in April 3 Federal Register. Briefing scheduled to update consumers on agency's protective efforts to prevent "mad cow disease" from entering U.S. and contaminating American food supply. For further information, contact FDA's Karen Mahoney at (301)-827-4393
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: